CIITA and Sepsis: The aim of this study was to evaluate whether monitoring of HLA-DR by qRT-PCR supports previous reports describing significant reduced expression levels of HLA-DRA and class II transactivator (CIITA) in patients with sepsis [23,24] and, furthermore, to assess how it correlates with traditional analysis performed by flow cytometry.